Treating the neurons and me — my mental states — in a synergistic way proved to speed up and enhance healing. It does for ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

"He fought for years to bring light to his post-NFL journey and the fears he had around his struggles and symptoms that he ...

NervGen is engaged in groundbreaking research in spinal cord injury treatment. Read here for an update on the research's ...

Preliminary unaudited fourth quarter and full year revenue 2024 was $22.1 and $74.5, respectivelyClosed acquisition of Greenbrook TMS effective as of December 9, 2024Expects full year 2025 pro forma ...

A man has been charged after a crash between a van and a horse in Cornwall, police have said. An eight-year-old girl was ...

The company's recent acquisition of Greenbrook TMS, a network of mental health treatment clinics, has been cited as a transformative move for Neuronetics. Post-acquisition adjustments reveal a pro ...

We are pleased to announce that our applications for the higher dose regimen of nusinersen are now under review in the US and Europe,” said Stephanie Fradette, Pharm.D., Head of the Neuromuscular ...

Spinraza remains a big product for Biogen but has seen its sales go into reverse as competition in SMA treatment has emerged ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Cell replacement therapy is making massive strides for other diseases. But what about Huntington’s disease? Can we use ...